NCT01062191

Brief Summary

The objective of this study is to evaluate the difference in joint range of motion of a new flexible hydrogel nanoparticle wound dressing compared to typical sodium carboxymethylcellulose dressing Aquacel AG for treatment of partial thickness burns.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2007

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2007

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2008

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

February 2, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 4, 2010

Completed
Last Updated

June 8, 2011

Status Verified

June 1, 2011

Enrollment Period

1.4 years

First QC Date

February 2, 2010

Last Update Submit

June 7, 2011

Conditions

Keywords

hydrogeldressingburnjoint

Outcome Measures

Primary Outcomes (1)

  • Range of motion in burned joints with dressing in place as compared to control

    Up to 2 weeks

Secondary Outcomes (1)

  • Pain at joint with dressing in place

    up to 2 weeks

Study Arms (2)

Altrazeal Flexible Hydrogel Nanoparticle Wound Dressing

EXPERIMENTAL

Nanoflex Powder Dressing applied to joint

Device: Altrazeal Flexible Hydrogel Nanoparticle Wound Dressing

Aquacel AG, typical carboxymethylcellulose dressing

ACTIVE COMPARATOR

Sodium CMC dressing control applied to joint

Device: Aquacel AG, typical carboxymethylcellulose dressing

Interventions

4" X 4", Aquacel silver sheet

Aquacel AG, typical carboxymethylcellulose dressing

Wound dressing

Altrazeal Flexible Hydrogel Nanoparticle Wound Dressing

Eligibility Criteria

Age2 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female patient is at least 2 years of age;
  • Patient is in general good health;
  • Patient has partial thickness burn that crosses at least one peripheral joint axial to the proximal interphalangeal joints;
  • Patient has one unburned contralateral joint without major internal or external joint derangement to be used as control
  • Patient is willing and able to cooperate with the protocol for 30 days
  • Patient is capable of provided informed consent
  • Patient provides authorization for use and disclosure of protected health information

You may not qualify if:

  • Age less than 2 years;
  • Patient has superficial or full thickness burn wounds;
  • Patient has acutely infected wounds;
  • Patient has wounds with surrounding cellulites;
  • Patient has a history of hypersensitivity to any components of either the nanoparticle or sodium hydrocellulose dressing, or any know sensitivities to other hydrogel bandage treatments
  • Patient has a concurrent clinical condition, which in the judgment of the Investigator cold either pose a health risk to the patient while participating in this study, or could potentially influence the outcome of the study;
  • Patient is wearing any type of orthopedic device that may come in contact with the dressing;
  • Patient has history of poor wound healing, history of smoking, history of drug/alcohol abuse, any other skin/immune system condition that would increase likelihood of wound irritation, infection or increase chance of early termination
  • Patient has wound originating from chronic condition
  • Patients with history of any immunodeficiency syndrome or condition
  • Patients who have applied any dressing or medication (OTC or prescription) to the wound (within 48 hours of study? )
  • Patient has participated in a clinical research study within the last 30 days prior to enrollment;
  • Patient is unable to communicate or to cooperate with the investigator due to language problems, poor mental development, or impaired cerebral function

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UT Southwestern

Dallas, Texas, 75390, United States

Location

MeSH Terms

Conditions

Burns

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

February 2, 2010

First Posted

February 4, 2010

Study Start

May 1, 2007

Primary Completion

October 1, 2008

Study Completion

October 1, 2008

Last Updated

June 8, 2011

Record last verified: 2011-06

Locations